Cinctive Capital Management LP Sarepta Therapeutics, Inc. Transaction History

Cinctive Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$113.33 - $163.85 $5.58 Million - $8.07 Million	-49,231 Reduced 62.83%	29,129 $4.6 Million
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $7.34 Million - $11.1 Million	78,360 New	78,360 $10.1 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $839,895 - $1.2 Million	-13,300 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $1.03 Million - $1.32 Million	13,300 New	13,300 $1.2 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.